{"id":246036,"date":"2026-09-15T13:43:44","date_gmt":"2026-09-15T08:13:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=246036"},"modified":"2026-09-15T13:43:47","modified_gmt":"2026-09-15T08:13:47","slug":"lasa-supergenerics-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Lasa Supergenerics Bull Case vs Bear Case for 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Lasa Supergenerics CMP Rs 6.20 on 15 Sep 2026. 52W High Rs 14.08, Low Rs 5.67. PE not meaningful (loss making) vs sector 51.01. RSI 13.24.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">The Lasa Supergenerics bull case for 2026 points toward the stock retesting its 52 week high of Rs 14.08, built on the strengths discussed below. The Lasa Supergenerics bear case points toward a slide back near its 52 week low of Rs 5.67 if the risks play out instead. The stock currently trades at Rs 6.20, with a loss making bottom line, so the industry average PE of 51.01 is the reference point for any future re-rating. The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n<p>The Lasa Supergenerics bull case is under the spotlight as investors weigh Lasa Supergenerics&#8217; recent price action against its underlying fundamentals. The stock trades at Rs 6.20, against a 52 week high of Rs 14.08 and a 52 week low of Rs 5.67, leaving room for both the Lasa Supergenerics bull case and the Lasa Supergenerics bear case to find support in the data.<\/p>\n<p>Lasa Supergenerics operates in the Active Pharmaceutical Ingredients Manufacturing space, and its return on equity of -26.30 percent and debt to equity ratio of 0.20 form the backbone of the fundamental picture. This article lays out the full Lasa Supergenerics bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n<p style=\"margin-top: 24px;\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Lasa_Supergenerics_Company_Overview\" title=\"Lasa Supergenerics Company Overview\">Lasa Supergenerics Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#The_Lasa_Supergenerics_Bull_Case\" title=\"The Lasa Supergenerics Bull Case\">The Lasa Supergenerics Bull Case<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Trading_Below_Book_Value\" title=\"Trading Below Book Value\">Trading Below Book Value<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Manageable_Leverage\" title=\"Manageable Leverage\">Manageable Leverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Extremely_Deeply_Oversold_Setup\" title=\"Extremely Deeply Oversold Setup\">Extremely Deeply Oversold Setup<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Trading_Above_Its_52_Week_Low\" title=\"Trading Above Its 52 Week Low\">Trading Above Its 52 Week Low<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#The_Lasa_Supergenerics_Bear_Case\" title=\"The Lasa Supergenerics Bear Case\">The Lasa Supergenerics Bear Case<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Ongoing_Losses\" title=\"Ongoing Losses\">Ongoing Losses<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#No_Current_Dividend\" title=\"No Current Dividend\">No Current Dividend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Extraordinarily_Sharp_Decline_From_52_Week_High\" title=\"Extraordinarily Sharp Decline From 52 Week High\">Extraordinarily Sharp Decline From 52 Week High<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Extremely_High_Speculative_Risk_at_a_Low_Absolute_Price\" title=\"Extremely High Speculative Risk at a Low Absolute Price\">Extremely High Speculative Risk at a Low Absolute Price<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Lasa_Supergenerics_Bull_vs_Bear_Scenario_Table\" title=\"Lasa Supergenerics Bull vs Bear Scenario Table\">Lasa Supergenerics Bull vs Bear Scenario Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_Could_Tip_the_Balance_Between_the_Bull_and_Bear_Case\" title=\"What Could Tip the Balance Between the Bull and Bear Case\">What Could Tip the Balance Between the Bull and Bear Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#How_to_Invest_in_Lasa_Supergenerics\" title=\"How to Invest in Lasa Supergenerics\">How to Invest in Lasa Supergenerics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#FAQs_on_Lasa_Supergenerics_Bull_Case_vs_Bear_Case\" title=\"FAQs on Lasa Supergenerics Bull Case vs Bear Case\">FAQs on Lasa Supergenerics Bull Case vs Bear Case<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_is_the_Lasa_Supergenerics_bull_case_for_2026\" title=\"What is the Lasa Supergenerics bull case for 2026?\">What is the Lasa Supergenerics bull case for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_is_the_Lasa_Supergenerics_bear_case_for_2026\" title=\"What is the Lasa Supergenerics bear case for 2026?\">What is the Lasa Supergenerics bear case for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Should_I_buy_Lasa_Supergenerics_share_now\" title=\"Should I buy Lasa Supergenerics share now?\">Should I buy Lasa Supergenerics share now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_are_the_key_risks_in_the_Lasa_Supergenerics_bear_case\" title=\"What are the key risks in the Lasa Supergenerics bear case?\">What are the key risks in the Lasa Supergenerics bear case?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_are_the_main_catalysts_for_the_Lasa_Supergenerics_bull_case\" title=\"What are the main catalysts for the Lasa Supergenerics bull case?\">What are the main catalysts for the Lasa Supergenerics bull case?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#Where_can_I_track_Lasa_Supergenerics_share_price_live\" title=\"Where can I track Lasa Supergenerics share price live?\">Where can I track Lasa Supergenerics share price live?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#What_is_the_52_week_high_and_low_of_Lasa_Supergenerics\" title=\"What is the 52 week high and low of Lasa Supergenerics?\">What is the 52 week high and low of Lasa Supergenerics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-bull-case-vs-bear-case-2026\/#How_can_I_buy_Lasa_Supergenerics_shares\" title=\"How can I buy Lasa Supergenerics shares?\">How can I buy Lasa Supergenerics shares?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Lasa_Supergenerics_Company_Overview\"><\/span><strong>Lasa Supergenerics Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td><strong>Metric<\/strong><\/td>\n<td><strong>Value<\/strong><\/td>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/lasa\/lasa-supergenerics-ltd-share-price-today\">Lasa Supergenerics<\/a> (LASA)<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Active Pharmaceutical Ingredients Manufacturing<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 6.20<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 14.08<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 5.67<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 33 Crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>not meaningful (loss making) (Industry PE 51.01)<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>-26.30 percent<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.20<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Lasa Supergenerics reports earnings per share of Rs -3.30, a book value of Rs 9.90 per share and a dividend yield of 0.00 percent at the current price. These fundamentals form the base data behind the Lasa Supergenerics bull case discussed below.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Lasa_Supergenerics_Bull_Case\"><\/span><strong>The Lasa Supergenerics Bull Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Trading_Below_Book_Value\"><\/span><strong>Trading Below Book Value<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Lasa Supergenerics trades at a book value of Rs 9.90 per share against a market price of Rs 6.20, a discount to its accounting net worth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Manageable_Leverage\"><\/span><strong>Manageable Leverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A debt to equity ratio of 0.20 keeps the balance sheet reasonably conservative.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Extremely_Deeply_Oversold_Setup\"><\/span><strong>Extremely Deeply Oversold Setup<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 14 day RSI near 13.24 places the stock in extremely oversold territory, a level rarely seen and one some contrarian investors watch very closely for a potential sharp technical bounce.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Trading_Above_Its_52_Week_Low\"><\/span><strong>Trading Above Its 52 Week Low<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades above its 52 week low of Rs 5.67, suggesting some stabilisation in investor sentiment recently.<\/p>\n<p>Taken together, these factors form the core of the Lasa Supergenerics bull case for the stock. This is one of the data points investors citing the Lasa Supergenerics bull case point to most often. Taken together, these factors are the foundation of the Lasa Supergenerics bull case for Lasa Supergenerics. Analysts who lean toward the Lasa Supergenerics bull case tend to weigh this factor heavily.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Lasa_Supergenerics_Bear_Case\"><\/span><strong>The Lasa Supergenerics Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Ongoing_Losses\"><\/span><strong>Ongoing Losses<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company reported a return on equity of negative 26.30 percent and negative earnings per share of Rs 3.30, reflecting a currently loss making business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"No_Current_Dividend\"><\/span><strong>No Current Dividend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A 0 percent dividend yield means the stock currently offers no income cushion for shareholders.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Extraordinarily_Sharp_Decline_From_52_Week_High\"><\/span><strong>Extraordinarily Sharp Decline From 52 Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at roughly 44 percent of its 52 week high of Rs 14.08, reflecting an extraordinarily significant de-rating over the past year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Extremely_High_Speculative_Risk_at_a_Low_Absolute_Price\"><\/span><strong>Extremely High Speculative Risk at a Low Absolute Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Trading at a low single-digit price combined with sustained losses, this stock sits at the far riskier end of the market and is suited only to investors who fully understand and accept a high risk of capital loss.<\/p>\n<p>Weighed against the Lasa Supergenerics bull case, these risks are what could keep the stock anchored closer to its recent lows.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Lasa_Supergenerics_Bull_vs_Bear_Scenario_Table\"><\/span><strong>Lasa Supergenerics Bull vs Bear Scenario Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td><strong>Scenario<\/strong><\/td>\n<td><strong>Reference Price Level<\/strong><\/td>\n<td><strong>Key Driver<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Retest of 52 week high, Rs 14.08<\/td>\n<td>Strengths outlined above play out and sentiment improves<\/td>\n<\/tr>\n<tr>\n<td>Current Price<\/td>\n<td>Rs 6.20<\/td>\n<td>Present market price as of 15 Sep 2026<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Retest of 52 week low, Rs 5.67<\/td>\n<td>Risks outlined above dominate and sentiment weakens<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Using the stock&#8217;s own 52 week trading range as the reference band keeps both the Lasa Supergenerics bull case and the bear case anchored to real, observed price levels rather than a speculative external forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Could_Tip_the_Balance_Between_the_Bull_and_Bear_Case\"><\/span><strong>What Could Tip the Balance Between the Bull and Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The most direct signal to watch for Lasa Supergenerics is the next couple of quarterly results, since earnings trends will either support or undercut the Lasa Supergenerics bull case laid out above. A stretch of steady execution and stable sector conditions would strengthen the bull case, while any deterioration in the specific risks flagged in the bear case would tilt the balance the other way.<\/p>\n<p>Broader sector trends in active pharmaceutical ingredients manufacturing and overall market risk appetite are the other variables worth tracking through the rest of 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Lasa_Supergenerics\"><\/span><strong>How to Invest in Lasa Supergenerics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors weighing the Lasa Supergenerics bull case against the bear case can use the Univest Screener to check live fundamentals, valuation ratios and peer comparisons before making a decision.<\/p>\n<p style=\"margin-top: 24px;\"><strong>Check the Univest Screener for Live Lasa Supergenerics Data<\/strong><\/p>\n<p>Start by opening a demat and trading account with a SEBI registered broker if you do not already have one active.<\/p>\n<p>Review Lasa Supergenerics&#8217; quarterly results and sector trends to see which case the latest data supports.<\/p>\n<p>Weigh the Lasa Supergenerics bull case upside against the bear case downside relative to the current market price to gauge the risk to reward on offer.<\/p>\n<p>Size any position according to your own risk tolerance, since both scenarios discussed here are illustrative and not guaranteed outcomes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Lasa Supergenerics bull case rests on the strengths outlined above playing out as earnings and sector conditions evolve, while the bear case reflects the risks that could keep the stock anchored closer to its 52 week low. Whether the Lasa Supergenerics bull case or the bear case plays out will likely become clearer over the next couple of quarters of results and sector data.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the Univest iOS App or Univest Android App to track Lasa Supergenerics live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Lasa_Supergenerics_Bull_Case_vs_Bear_Case\"><\/span><strong>FAQs on Lasa Supergenerics Bull Case vs Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lasa_Supergenerics_bull_case_for_2026\"><\/span><strong>What is the Lasa Supergenerics bull case for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Lasa Supergenerics bull case for 2026 is built on trading below book value and manageable leverage, with the stock able to retest its 52 week high of Rs 14.08 if these strengths continue to play out.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lasa_Supergenerics_bear_case_for_2026\"><\/span><strong>What is the Lasa Supergenerics bear case for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Lasa Supergenerics bear case for 2026 centres on ongoing losses and no current dividend, with the stock at risk of retesting its 52 week low of Rs 5.67 if these risks dominate.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_buy_Lasa_Supergenerics_share_now\"><\/span><strong>Should I buy Lasa Supergenerics share now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lasa Supergenerics trades at Rs 6.20, and whether it fits your portfolio depends on how you weigh the Lasa Supergenerics bull case against the bear case risks discussed in this article, ideally after confirming with a SEBI registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_in_the_Lasa_Supergenerics_bear_case\"><\/span><strong>What are the key risks in the Lasa Supergenerics bear case?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks in the Lasa Supergenerics bear case include ongoing losses, no current dividend and extraordinarily sharp decline from 52 week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_catalysts_for_the_Lasa_Supergenerics_bull_case\"><\/span><strong>What are the main catalysts for the Lasa Supergenerics bull case?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main catalysts for the Lasa Supergenerics bull case are trading below book value, manageable leverage and extremely deeply oversold setup.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Lasa_Supergenerics_share_price_live\"><\/span><strong>Where can I track Lasa Supergenerics share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Lasa Supergenerics share price live on the Univest Screener, which shows CMP, volume, valuation ratios and other fundamentals updated through the trading session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Lasa_Supergenerics\"><\/span><strong>What is the 52 week high and low of Lasa Supergenerics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Lasa Supergenerics is Rs 14.08 and the 52 week low is Rs 5.67, with the stock currently trading at Rs 6.20.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_buy_Lasa_Supergenerics_shares\"><\/span><strong>How can I buy Lasa Supergenerics shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy Lasa Supergenerics shares through any SEBI registered stockbroker by placing an order on the NSE or BSE during market hours, after reviewing the company&#8217;s fundamentals and your own investment goals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lasa Supergenerics bull case and bear case for 2026, based on CMP Rs 6.20, 52 week range Rs 5.67 to Rs 14.08, valuation and technical data.<\/p>\n","protected":false},"author":35,"featured_media":246035,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-246036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["246035"],"_edit_lock":["1789460029:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["66"],"rank_math_title":["Lasa Supergenerics Bull Case vs Bear Case 2026"],"rank_math_description":["Lasa Supergenerics bull case and bear case for 2026, based on CMP Rs 6.20, 52 week range Rs 5.67 to Rs 14.08, valuation and technical data."],"rank_math_focus_keyword":["Lasa Supergenerics"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["43137"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/lasa-supergenerics-share-bull-case-vs-bear-case-2026.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=246036"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246036\/revisions"}],"predecessor-version":[{"id":246886,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246036\/revisions\/246886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/246035"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=246036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=246036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=246036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}